Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Lycopene Supplementation in Prostate Cancer
NCT00450749Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Feb 2008
- Primary completion
- May 2010
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lycopene in prostate cancer (PCa) (3 arms), sponsored by National Cancer Institute. Primary endpoints: Concentration of Lycopene in Prostatic Surgical Tissue and Serum Levels of Total Lycopene at 7 weeks. Started Feb 2008; status: completed.
02
Drugs
lycopene
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00450749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00450749.